| [1] |
Li S, Bai L, Dong J, et al. Kaposi's sarcoma⁃associated herpesvirus: epidemiology and molecular biology[J]. Adv Exp Med Biol, 2017,1018:91⁃127. DOI: 10.1007/978⁃981⁃10⁃5765⁃6_7.
|
| [2] |
Lopes AO, Marinho P, Medeiros L, et al. Human gammaherpesvirus 8 oncogenes associated with Kaposi's sarcoma[J]. Int J Mol Sci, 2022,23(13) :7023. DOI: 10.3390/ijms23137203.
|
| [3] |
Iloukou PJ, Boumba AL, Ngombe DF, et al. Molecular detection and genotyping of human herpes virus 8 in blood donors in Congo[J]. Vopr Virusol, 2024,69(3):277⁃284. DOI: 10.36233/0507⁃4088⁃237.
|
| [4] |
Iftode N, Rădulescu MA, Aramă ȘS, et al. Update on Kaposi sarcoma⁃associated herpesvirus (KSHV or HHV8) ⁃ review[J]. Rom J Intern Med, 2020,58(4):199⁃208. DOI: 10.2478/rjim⁃2020⁃0017.
|
| [5] |
中国医师协会皮肤科医师分会, 中国研究型医院学会皮肤科学专业委员会. 中国卡波西肉瘤诊疗专家共识(2023版)[J]. 中华皮肤科杂志, 2023,56(10):899⁃906. DOI: 10.35541/cjd. 20230261.
|
| [6] |
Speicher DJ, Fryk JJ, Kashchuk V, et al. Human herpesvirus 8 in Australia: DNAemia and cumulative exposure in blood donors[J]. Viruses, 2022,14(10) :2185. DOI: 10.3390/v14102185.
|
| [7] |
Fu B, Sun F, Li B, et al. Seroprevalence of Kaposi's sarcoma⁃associated herpesvirus and risk factors in Xinjiang, China[J]. J Med Virol, 2009,81(8):1422⁃1431. DOI: 10.1002/jmv.21550.
|
| [8] |
Fang Y, Li W, Zhang Y, et al. Seroprevalence of Kaposi's sarcoma⁃associated herpesvirus and risk factors in Jiuquan area, China[J]. J Med Virol, 2022,94(12):6016⁃6022. DOI: 10.1002/jmv.28045.
|
| [9] |
Wang H, Liu J, Dilimulati, et al. Seroprevalence and risk factors of Kaposi's sarcoma⁃associated herpesvirus infection among the general Uygur population from south and north region of Xinjiang, China[J]. Virol J, 2011,8:539. DOI: 10.1186/1743⁃422X⁃8⁃539.
|
| [10] |
Zhang X, Fang Q, Zhu S, et al. Environmental risk factors and genetic markers of Kaposi's sarcoma⁃associated herpesvirus infection among Uygur population in Xinjiang, China[J]. J Med Virol, 2022,94(6):2755⁃2765. DOI: 10.1002/jmv.27600.
|
| [11] |
Etemad SA, Dewan AK. Kaposi sarcoma updates[J]. Dermatol Clin, 2019,37(4):505⁃517. DOI: 10.1016/j.det.2019.05.008.
|
| [12] |
Zhang J, Wang P, Li T, et al. Association between human herpesvirus 8 and lipid profile in northwest China: a cross⁃sectional study[J]. J Med Virol, 2024,96(8):e29794. DOI: 10.1002/jmv.29794.
|
| [13] |
Yuan H, Liu Z, Wu X, et al. Social behavioral correlates of Kaposi sarcoma⁃associated herpesvirus infection among Han and Uygur populations in Xinjiang, China[J]. J Med Virol, 2019,91(3):457⁃462. DOI: 10.1002/jmv.25332.
|
| [14] |
WHO Expert Consultation. Appropriate body⁃mass index for Asian populations and its implications for policy and intervention strategies[J]. Lancet, 2004,363(9403):157⁃163. DOI: 10.1016/S0140⁃6736(03)15268⁃3.
|
| [15] |
Chinna P, Bratl K, Lambarey H, et al. The impact of co⁃infections for human gammaherpesvirus infection and associated pathologies[J]. Int J Mol Sci, 2023, 24(17):13066. DOI: 10. 3390/ijms241713066.
|
| [16] |
Santiago JC, Goldman JD, Zhao H, et al. Intra⁃host changes in Kaposi sarcoma⁃associated herpesvirus genomes in Ugandan adults with Kaposi sarcoma[J]. PLoS Pathog, 2021,17(1):e1008594. DOI: 10.1371/journal.ppat.1008594.
|
| [17] |
Crabtree KL, Wojcicki JM, Minhas V, et al. Association of household food⁃ and drink⁃sharing practices with human herpesvirus 8 seroconversion in a cohort of Zambian children[J]. J Infect Dis, 2017,216(7):842⁃849. DOI: 10.1093/infdis/jix399.
|
| [18] |
Faden A, AlSheddi M, AlKindi M, et al. Oral Kaposi sarcoma in HIV⁃seronegative Saudi patient: literature review and case report[J]. Saudi Dent J, 2017,29(3):129⁃134. DOI: 10.1016/j.sdentj. 2017.03.003.
|
| [19] |
Sgadari C, Scoppio B, Picconi O, et al. Clinical efficacy of the HIV protease inhibitor indinavir in combination with chemotherapy for advanced classic Kaposi sarcoma treatment: a single⁃arm, phase Ⅱ trial in the elderly[J]. Cancer Res Commun, 2024,4(8):2112⁃2122. DOI: 10.1158/2767⁃9764.CRC⁃24⁃0102.
|
| [20] |
Han C, Gui C, Dong S, et al. The interplay between KSHV infection and DNA⁃sensing pathways[J]. Viruses, 2024,16(5):749. DOI: 10.3390/v16050749.
|
| [21] |
Headley SA, de Lemos G, Dall Agnol AM, et al. Ovine gammaherpesvirus 2 infections in cattle without typical manifestations of sheep⁃associated malignant catarrhal fever and concomitantly infected with bovine coronavirus[J]. Braz J Microbiol, 2022,53(1):433⁃446. DOI: 10.1007/s42770⁃021⁃00653⁃6.
|
| [22] |
Lontchi⁃Yimagou E, Dasgupta R, Anoop S, et al. An atypical form of diabetes among individuals with low BMI[J]. Diabetes Care, 2022,45(6):1428⁃1437. DOI: 10.2337/dc21⁃1957.
|
| [23] |
Popkin BM, Du S, Green WD, et al. Individuals with obesity and COVID⁃19: a global perspective on the epidemiology and biological relationships[J]. Obes Rev, 2020,21(11):e13128. DOI: 10.1111/obr.13128.
|
| [24] |
Moser JS, Galindo⁃Fraga A, Ortiz⁃Hernández AA, et al. Underweight, overweight, and obesity as independent risk factors for hospitalization in adults and children from influenza and other respiratory viruses[J]. Influenza Other Respir Viruses, 2019,13(1):3⁃9. DOI: 10.1111/irv.12618.
|
| [25] |
Cui M, Fang Q, Zheng J, et al. Kaposi's sarcoma⁃associated herpesvirus seropositivity is associated with type 2 diabetes mellitus: a case⁃control study in Xinjiang, China[J]. Int J Infect Dis, 2019,80:73⁃79. DOI: 10.1016/j.ijid.2019.01.003.
|
| [26] |
Sobngwi E, Choukem SP, Agbalika F, et al. Ketosis⁃prone type 2 diabetes mellitus and human herpesvirus 8 infection in sub⁃saharan africans[J]. JAMA, 2008,299(23):2770⁃2776. DOI: 10.1001/jama.299.23.2770.
|
| [27] |
Mbulaiteye SM, Atkinson JO, Whitby D, et al. Risk factors for human herpesvirus 8 seropositivity in the AIDS Cancer Cohort Study[J]. J Clin Virol, 2006,35(4):442⁃449. DOI: 10.1016/j.jcv.2005.10.010.
|
| [28] |
Motlhale M, Sitas F, Bradshaw D, et al. Lifestyle factors associated with sex differences in Kaposi sarcoma incidence among adult black South Africans: a case⁃control study[J]. Cancer Epidemiol, 2022,78:102158. DOI: 10.1016/j.canep.2022. 102158.
|
| [29] |
Ziegler J, Newton R, Bourboulia D, et al. Risk factors for Kaposi's sarcoma: a case⁃control study of HIV⁃seronegative people in Uganda[J]. Int J Cancer, 2003,103(2):233⁃240. DOI: 10.1002/ijc.10818.
|
| [30] |
Wang L, Liu Z, Xu Z, et al. Repurposing alcohol⁃abuse drug disulfiram for the treatment of KSHV⁃infected primary effusion lymphoma by activating antiviral innate immunity[J]. PLoS Pathog, 2025,21(3):e1012957. DOI: 10.1371/journal.ppat.101 2957.
|